Treximet Sample Case Design
Tuesday, March 31st, 2009The good news is that when I was at the doctor’s last week, I managed to get a hold of a box of Treximet samples. The bad news is that I managed to get a hold of a box of Treximet samples. Although it sounded at first like I’d struck gold getting the sample box, things turned south mighty fast when I opened the box and saw the packaging the Treximet is in.
Yet Another Reason to Hate GSK
Treximet is made by GlaxoSmithKlien (nee: SmithKline Beecham). I have family who used to work at GSK and that’s one reason why I hate Big Phrama so much — because I got to see firsthand how they waste money in order to justify jacking up prices.
Case in point — the Treximet sample cases. I don’t know for sure if the Marquis deSade has any decnedants, but if he does, this has got to be the person who designed this prurple plastic torture device.
What’s So Bad About It?
I’m glad you asked. Just imagine yourself with a migraine — you’re shaking, you can barely see because the slightest bit of light feels like staring into the heart of the sun and you are this < --> close to throwing up.
But AHH, you have the Treximet. Hope, for one shining moment, gleams with the promise of a rainbow after a storm.
And then you try to open the case.
First off, you have to squeeze the sides. Not just any sides — two specific places on the sides. If you’re off by a millimeter, you’re screwed. Then, after you’re squeezing, the case is suppossed to pop open. Except it only pops open a centimeter. You then have to pry a hyperdermic needle (or something similar) under the ridge and push up.
Needless to say, I have had a migraine since getting the Treximet and I could not actually get to the Treximet because I could not open the freaking case.
I hate you, GSK.
Ever envied guinea pigs? Lord knows I have. Well, you may not have the fuzzy fur or the little pink lips or the jellybean-like physique, but you can play the metaphorical guinea pig in helping out with a
People with migraines or cluster headaches may be perscribed anti-convulsants at one point or another. As their name implies, these are drugs that were originally meant for helping people with epilespy or other conditions that cause seizures. Now, anti-convulsants are prescribed off-label for bipolar disorder, schitzophrenia, Alzheimer’s, obsessive-compulsive disorder, restless leg syndrome, drug addiction rehabilitation and pre-menstrual syndrome.
I forgot all about submitting to the March 2009 edition of the Headache and Migraine Blog Carnival. (DUH!) And I get two reminders, as well. I guess I could blame
Recently, I had a client ask me if I was interested in doing a series of articles on vascular migraines. (Remember, I’m not a doctor –I just know too much.) I’d never heard of vascular migraines. I am familiar with the now mostly shelved theory that migraines are caused by blood vessels ( the vascular system) expanding and contracting. (It’s not thought that
A happy thought for a Monday, I’m sure. But if you are a woman with migraines, you can’t take your heart health for granted. You will be more prone to having heart attacks and strokes than women who don’t have migraines. Yet more proof that life is not fair.
Many migraineurs are prescribed beta-blockers taken daily in order to prevent migraines. This is an off-label use, but many migraineurs have benefited. Now, a Dutch study has come out suggesting that beta-blockers may have another potential off-label use —
Only on the blogosphere do migraines and sex go together. Most times migraine pain makes sex impossible, although a few migrainers claim that the release of the orgasm can help temporarily relieve pain. If you are having sex and suddenly get the worst migraine you ever have, then call an ambulance.
It’s cold, heavy, slippery and needs to be removed from vehicles, roofs and roads. Depending on where you live, if you don’t shovel and salt your walk within 24 hours of a storm, you get fined. But snow also has yet another evil invloved with it — it can be a migraine trigger.
Migraines cost a lot of money and time, not only for the migraineur, but for their employers, their families and for society at large, so more attention needs to be paid to treating this disease. This was the conclusion of a new study published in Value in Health. It has the exhausting title of